Mangalam Drugs VS Pharmaceuticals & Biotechnology 
1D
-4.99%
0.19%
1W
-10.2%
1.71%
1M
18.77%
-2.1%
YTD
30.9%
-1.35%
1Y
-66.66%
8.58%
3Y
-68.32%
44.37%
5Y
-73.81%
73.04%
10Y
-83.35%
248.14%
- Stock Absolute Returns
- Absolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-45.32%
0%
-45.32%
6 Months
-59.84%
0%
-59.84%
1 Year
-66.66%
0%
-66.66%
2 Years
-66.17%
0%
-66.17%
3 Years
-68.32%
0%
-68.32%
4 Years
-72.88%
0%
-72.88%
5 Years
-73.81%
0%
-73.81%
Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Mangalam Drugs and Organics Ltd has not been a consistent performer in the last 1 year and longer periods
2
Quartile
QTD
37.77%
4
Quartile
Sep-Dec
-61.59%
4
Quartile
Jun-Sep
-11.25%
4
Quartile
1Y
-64.91%
4
Quartile
2025
-76.18%
1
Quartile
2024
17.66%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Mangalam Drugs and Organics Ltd has been in the Third and Fourth Quartile in the last 1 year and longer periods
1
Quartile
QTD
37.77%
4
Quartile
Sep-Dec
-61.59%
3
Quartile
Jun-Sep
-11.25%
4
Quartile
1Y
-64.91%
4
Quartile
2025
-76.18%
3
Quartile
2024
17.66%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s Risk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
